| Pascal Olivier Zinn, MD, PHD | |
|
5150 Centre Ave Ste 433, Pittsburgh, PA 15232-1309 | |
| (412) 647-7614 | |
| (412) 623-4653 |
| Full Name | Pascal Olivier Zinn |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 17 Years |
| Location | 5150 Centre Ave Ste 433, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053674689 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | BP10044190 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Upmc Passavant | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, questionnaires can help dentists screen for sleep-disordered breathing in a pediatric population. SDB includes obstructive sleep apnea, upper-airway resistance syndrome, and snoring.
A portable biosensor that could show how disease is progressing in patients with Alzheimer's could greatly improve people's quality of life in the future, according to a new review published in Biosensors and Bioelectronics.
The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.
ARIAD Pharmaceuticals, Inc. today announced the completion of patient enrollment in its pivotal, Phase 3 clinical trial of oral ridaforolimus, its investigational mTOR inhibitor, in patients with metastatic soft-tissue and bone sarcomas.
› Verified 2 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, questionnaires can help dentists screen for sleep-disordered breathing in a pediatric population. SDB includes obstructive sleep apnea, upper-airway resistance syndrome, and snoring.
A portable biosensor that could show how disease is progressing in patients with Alzheimer's could greatly improve people's quality of life in the future, according to a new review published in Biosensors and Bioelectronics.
The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.
ARIAD Pharmaceuticals, Inc. today announced the completion of patient enrollment in its pivotal, Phase 3 clinical trial of oral ridaforolimus, its investigational mTOR inhibitor, in patients with metastatic soft-tissue and bone sarcomas.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pascal Olivier Zinn, MD, PHD 5150 Centre Ave Ste 433, Pittsburgh, PA 15232-1309 Ph: (126) 477-6144 | Pascal Olivier Zinn, MD, PHD 5150 Centre Ave Ste 433, Pittsburgh, PA 15232-1309 Ph: (412) 647-7614 |
News Archive
According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, questionnaires can help dentists screen for sleep-disordered breathing in a pediatric population. SDB includes obstructive sleep apnea, upper-airway resistance syndrome, and snoring.
A portable biosensor that could show how disease is progressing in patients with Alzheimer's could greatly improve people's quality of life in the future, according to a new review published in Biosensors and Bioelectronics.
The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.
ARIAD Pharmaceuticals, Inc. today announced the completion of patient enrollment in its pivotal, Phase 3 clinical trial of oral ridaforolimus, its investigational mTOR inhibitor, in patients with metastatic soft-tissue and bone sarcomas.
› Verified 2 days ago
Enyinna L Nwachuku, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St, Suite B-400, Pittsburgh, PA 15213 Phone: 412-647-6777 Fax: 412-647-6483 | |
David Zorub, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5200 Centre Ave, Suite 617, Pittsburgh, PA 15232 Phone: 412-623-2972 | |
David Kaufmann, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St, Suite 300, Pittsburgh, PA 15219 Phone: 412-471-4772 | |
Sean Polster, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 203 Lothrop St Ste 521, Suite B400, Pittsburgh, PA 15213 Phone: 412-647-8186 | |
Dr. Ali Fadhil, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St Ste 311, Pittsburgh, PA 15219 Phone: 412-647-2304 | |
Daryl Pinion Fields Ii, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St Ste B-400, Pittsburgh, PA 15213 Phone: 320-224-2705 |